GSK opens new plant in Parma


GSK  20/10/2018 - The research-based pharmaceutical company GlaxoSmithKline, headquartered in Uk, expands its presence in San Polo di Torrile (Parma) with a 1,500 sq. m plant devoted to production and packaging of a medicine for Hiv-treatment, investing 30 million euro.

The Plant Director Maria Chiara Amadei stated: “Parma has given an important contribute (…) in the deep technological and innovative transformation that is revolutionizing the health sector at global level”.

 

Source: https://www.gsk.it/sala-stampa/hiv-da-parma-innovazione-industria-e-cure-per-i-pazienti-di-tutto-il-mondo

 

 

 

 

Strumenti personali

Invest è realizzato da ART-ER S. cons. p. a. su incarico della Regione Emilia-Romagna

Sede: Via Morgagni, 6 - 40122 Bologna tel. 051/6450411 - P.I. 03786281208 - e-mail: investinemiliaromagna@ervet.it - info@ervet.it